News

According to a new report by Fact.MR, the global fortified wine market is projected to register a low single-digit CAGR during the forecast period 2017 to 2022. Majority of people believe premium products to contain high-quality ingredients. Product premiumization is therefore considered as a major strategy adopted by market players in order to fuel adoption of fortified wine worldwide. Revenues from global sales of fortified wine are estimated to account for approximately US$ 2,000 Mn by 2022-end.

Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=163

Fact.MR, in its latest market study, opines that the home diagnostics market will grow at a healthy 3.5% value CAGR, surpassing US$ 6.3 million by 2026. According to the report, sales will remain buoyant in developed regions, with North America and Europe collectively accounting for over 50% revenue share of the market. The Fact.MR study remains bullish on the prospects of home diagnostics market players in developing countries, as growing focus on health & wellness, and emergence of many Asian countries as medical tourism hubs creates opportunities.

Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=1892

Global sales of kidney stone management devices are likely to surpass 1 million units by 2028, according to a new Fact.MR study. In terms of revenues, the study projects the kidney stone management devices market to surpass US$ 1,500 million.

Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=1827

Rising preferences for minimally-invasive and non-invasive surgical procedures continues to be a massive trend in the kidney stone management devices market. Growing incidence rate of kidney stones, combined with the availability of affordable minimally invasive treatment is likely to sustain demand for kidney stone management devices during the forecast period 2018-2028. The report opines that manufacturers will be hard-pressed to develop innovative devices for large stones, as it has remained a longstanding challenge for healthcare providers.

An above-average rise at 4.0% volume CAGR is foreseen for the syringes & cannulas market over the period of forecast, 2018 to 2028, by a new Fact.MR study. Pervasiveness of syringes in terms of the market volume share continues to prevail, whereas the growth rate will also remain higher for these products, compared to cannulas, through 2028. Additionally, majority volume share of worldwide syringes sales is estimated to remain hinged at disposable variants.

Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=2007

North America has traditionally remained the most remunerative market syringes & cannulas, however emergence of Asia-Pacific excluding Japan (APEJ) as a medical tourism hub has paved abundant opportunities for syringes & cannulas manufacturers. The U.S. continues to lead the North American market for syringes & cannulas, whereas majority of APEJ’s syringes and cannulas market continues to remain consolidated in India, trailed by China. The study finds that the U.S., India, and China collectively account for nearly 45% of the overall syringes & cannulas market.

Auf dem Weg zum Gesundheitssystem 4.0

Berlin, 28.06.2019 - Spätestens im Januar 2021 ist es soweit: Bis dahin müssen alle gesetzlichen Krankenkassen ihren Versicherten die elektronische Patientenakte (ePa) anbieten. Es ist ein wichtiger und längst überfälliger Schritt auf dem Weg zur Digitalisierung des deutschen Gesundheitssystems, das im europäischen Vergleich weit hinter anderen Ländern zurück bleibt.

Damit die deutschen Gesundheitsinstitutionen den von Gesundheitsminister Jens Spahn gesetzten Termin auch halten können, sind sie auf zuverlässige Partner der digitalen Informationsmanagement-Branche angewiesen. Ein solcher Partner ist die Berliner OPTIMAL SYSTEMS GmbH, die mit ihrer Enterprise Content Management-Software enaio® eine Variante der elektronischen Patientenakte anbietet. Damit ist es möglich, die Systeme zu vereinheitlichen und Schnittstellen zu schaffen, um den Datenaustausch zwischen Krankenkassen, niedergelassenen Ärzten und Krankenhäusern zu gewährleisten. Das gleichzeitige Bündeln von Verwaltungsdaten und medizinischen Befunden im enaio® System ist also eine Win-Win-Situation für alle Seiten.

Worldwide sales of the controlled substances closed in on a valuation of US$ 67,000 Mn in 2018, and are projected to record a Y-o-Y growth at 3.5% in 2019, according to a new Fact.MR study. The study opines that depressants and stimulants have been top-selling class of drugs in the controlled substances market, however gains from marijuana are expected to record over 2X faster growth than all the other controlled substances in 2019 and beyond.

Approval of medical marijuana has been on a significant uptick in various states of the US, trailed by the legalization in Canada for both recreational and medicinal use recently. This has tremendously contributed to the popularity of cannabis stocks, alongside efforts of leading controlled substance manufacturers toward eliminating legal barriers and attracting investor interest. The study estimates marijuana sales in 2019 to record a Y-o-Y growth at 9.3% over 2018.

Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=2032

The hormone replacement therapy market is foreseen to expand at a significant pace with sales of hormone replacement therapy products crossing US$ 12,000 Mn by 2019 end. Rising incidences of osteoporosis fractures coupled with growing menopause rates among women have remained instrumental in driving the demand for hormone replacement therapy. Fact.MR envisages that the demand for hormone replacement therapy is projected to expand at a CAGR of 6.0% in terms of value throughout the period of forecast, 2018-2028.

Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=2224

Disorders associated with hormonal imbalance continue to influence the use of hormone replacement therapy worldwide. Hormone replacement therapy demand is further pushed with macroeconomic aspects such as growing geriatric population and significant increase in healthcare expenditure worldwide. Growing age directly impacts secretion of hormones such as progesterone and estrogen in women, which is expected to trigger the use of estrogen hormone replacement therapy.

The rapidly advancing diagnostics space has resulted in development of various companies involved in production of diagnostic equipment as well as distribution of testing apparatus and assemblies. The histopathology testing equipment market is no exception, wherein top five companies involved in the development of histopathology testing equipment account for a significant share of the overall market revenue. Top companies such as Thermo Fisher Scientific, Hoffman-la-Roche Ltd., Leica Biosystems, Agilent Technologies Inc., and Merck KGaA collectively account for a revenue share of over 62% in the histopathology testing equipment market.

Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=2240

Increasing awareness regarding cancer screening coupled with higher demand for advanced histopathology testing equipment from diagnostic centers are expected to provide potential avenues of growth for tier 1 manufacturers. These companies are more focused on new product launches, expansion of their current product lines.

Fact.MR has recently published a fresh research report that carefully inspects the ENT surgical devices market for the period between 2018 and 2028. The study titled “ENT Surgical Devices Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028”, serves as an informative data source that includes knowledge associated to market dynamics, market value (US$ Mn), Y-o-Y growth comparison and a lot more. Overall, the concerned assessment unravels the actual scenario prevailing in the global ENT surgical devices market influenced by technological innovations and medical trends.

According to research findings, the global market for ENT surgical devices is likely to surpass US$ 2,500 million in 2019. Furthermore, the ENT surgical devices market is projected to grow at 6.4% CAGR by the end of 2028. This outstanding growth can be credited to certain motivating aspects such as technological advancements augmenting ENT procedure outcome and reimbursement policies favoring ENT surgeries.

Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=2454

Ongoing Implementation of Advanced Technology Supporting Market Growth

ENT diagnostic devices market is estimated to hit US$ 2.3 billion in 2019, according to a new study by Fact.MR. The market grew at 6.3% y-o-y in 2018 with bronchoscopes accounting for nearly one third of the global revenues. Overall growth of the ENT diagnostic devices market can be attributed to,

• Advanced technology incorporations in ENT diagnostic devices
• Favorable reimbursement policies for ENT procedures
• Development of efficient and low-priced devices

Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=2468

According to Fact.MR study, the ENT endoscopes are estimated to account for over half the revenues of the ENT diagnostic devices market in 2019. Endoscopy has played a significant role in the diagnosis of ear, nose and throat related diseases as well as successful treatment outcomes. Owing to this, ENT endoscopes have become the most common devices in the ENT clinics.